BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2464944)

  • 1. Transthyretin in endocrine pancreatic tumors.
    Jacobsson B; Carlström A; Collins VP; Grimelius L
    Am J Pathol; 1989 Feb; 134(2):465-71. PubMed ID: 2464944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular composition and anatomic distribution in nonfunctioning pancreatic endocrine tumors: immunohistochemical study of 30 cases.
    Zheng X; Guo K; Tian Y; Li J; Guo R; Zhan Y; Song M; Shen K
    Chin Med J (Engl); 1998 Apr; 111(4):373-6. PubMed ID: 10374408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein in pancreatic endocrine neoplasms.
    Tomita T
    Mod Pathol; 2000 Apr; 13(4):389-95. PubMed ID: 10786804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets.
    Jacobsson B; Collins VP; Grimelius L; Pettersson T; Sandstedt B; Carlström A
    J Histochem Cytochem; 1989 Jan; 37(1):31-7. PubMed ID: 2642294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
    Klöppel G; Girard J; Polak JM; Vaitukaitis JL; Kasper M; Heitz PU
    Cancer Detect Prev; 1983; 6(1-2):161-6. PubMed ID: 6309383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations.
    Bani Sacchi T; Bani D; Biliotti G
    Int J Pancreatol; 1989 Jul; 5(1):11-28. PubMed ID: 2568382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
    Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
    Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical patterns of islet cell tumors as defined by the monoclonal antibody HISL-19.
    Bordi C; Krisch K; Horvat G; Srikanta S
    Am J Pathol; 1988 Aug; 132(2):249-57. PubMed ID: 2840831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptophysin. A new marker for pancreatic neuroendocrine tumors.
    Chejfec G; Falkmer S; Grimelius L; Jacobsson B; Rodensjö M; Wiedenmann B; Franke WW; Lee I; Gould VE
    Am J Surg Pathol; 1987 Apr; 11(4):241-7. PubMed ID: 3032010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemistry of normal pancreatic islets and spontaneous islet cell tumors in dogs.
    Hawkins KL; Summers BA; Kuhajda FP; Smith CA
    Vet Pathol; 1987 Mar; 24(2):170-9. PubMed ID: 2883753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study on distribution of transthyretin in normal human brain tissue and tumors].
    Kunishio K; Shiraishi T; Mishima N; Matsumi N; Tamiya T; Honda C; Matsumoto K; Furuta T; Nishimoto A
    No To Shinkei; 1989 Mar; 41(3):245-9. PubMed ID: 2667588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of alpha-1-antitrypsin in pancreatic islet cell tumors.
    Prinz RA; Sandberg L
    J Med; 1984; 15(3):177-83. PubMed ID: 6098624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgery of endocrine pancreatic tumors. Results of a survey in the German Federal Republic].
    Kümmerle F; Rückert K
    Minerva Med; 1978 Nov; 69(58):3992-6. PubMed ID: 216955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
    Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
    Drucker DJ; Asa SL; Silverberg J; Brubaker PL
    Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.
    Bordi C; Pilato FP; D'Adda T
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):387-98. PubMed ID: 2845642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
    Tomita T; Kimmel JR; Friesen SR; Doull V; Pollock HG
    Cancer; 1985 Oct; 56(7):1649-57. PubMed ID: 2992743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas.
    Polak JM; Bloom SR; Adrian TE; Heitz P; Bryant MG; Pearse AG
    Lancet; 1976 Feb; 1(7955):328-30. PubMed ID: 54738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of pro-insulin, C-peptide, and insulin in nesidioblastosis, focal islet-cell adenomatosis, and genuine insulomas. A correlated radioimmunochemical, immunohistochemical, and ultrastructural investigation with particular regard to the occurrence of argyrophil and pro-insulin immunoreactive cells.
    Kohnert KD; Fält K; Odselius R; Ziegler M; Madsen OD; Grimelius L; Falkmer S
    Diabetes Res; 1988 Aug; 8(4):151-63. PubMed ID: 2853026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.